Thus, we set out to better define the expression and function of EphA3 in the TME, and to determine its requirement for supporting tumour development, using syngeneic tumours in transgenic mice with inducible shRNA-mediated knockdown of EphA3 expression. This evidence concerns the gene EPHA3 and neoplasm.